Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Youjin Kim

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
BMC Urology|May 5, 2019
A retrospective feasibility study of biweekly docetaxel in patients with high-risk metastatic castration-naïve prostate cancerSang Eun Yoon, Youjin Kim, Jangho Cho, et al.
Advanced Materials (Deerfield Beach, Fla.)|February 11, 2025
Rapid Drying Principle for High-speed, Pinhole-Less, Uniform Wet Deposition Protocols of Water-Dispersed 2D MaterialsKyeonghun Jeong, Chansoo Kim, Ha Young Lee, et al.
Oncotarget|December 30, 2017
MerTK inhibition by RXDX-106 in MerTK activated gastric cancer cell linesJung Eun Kim, Youjin Kim, Gary Li, et al.
Cancer Research and Treatment|September 8, 2018
Discordance of the PAM50 Intrinsic Subtypes Compared with Immunohistochemistry-Based Surrogate in Breast Cancer Patients: Potential Implication of Genomic Alterations of DiscordanceHee Kyung Kim, Kyung Hee Park, Youjin Kim, et al.
European Journal of Immunology|June 9, 2020
MDSC subtypes and CD39 expression on CD8<sup>+</sup> T cells predict the efficacy of anti-PD-1 immunotherapy in patients with advanced NSCLCJiae Koh, Youjin Kim, Kyoung Young Lee, et al.
Journal of Gastric Cancer|January 5, 2019
Adjuvant Chemotherapy with or without Concurrent Radiotherapy for Patients with Stage IB Gastric Cancer: a Subgroup Analysis of the Adjuvant Chemoradiotherapy in Stomach Tumors (ARTIST) Phase III TrialYoujin Kim, Kyoung-Mee Kim, Min Gew Choi, et al.
Journal of Gastric Cancer|July 20, 2016
The Influence of Metastatic Lymph Node Ratio on the Treatment Outcomes in the Adjuvant Chemoradiotherapy in Stomach Tumors (ARTIST) Trial: A Phase III TrialYoujin Kim, Se Hoon Park, Kyoung-Mee Kim, et al.
Cancer|January 20, 2017
Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01)Youjin Kim, Su Jin Lee, Ji Yun Lee, et al.
Cancer Research and Treatment|April 19, 2024
Analysis of Response and Progression Patterns of Tyrosine Kinase Inhibitors in Recurrent or Metastatic Adenoid Cystic Carcinoma: A Post Hoc Analysis of Two KCSG Phase II TrialsYoujin Kim, Bhumsuk Keam, Eun Joo Kang, et al.
Cancer Discovery|July 19, 2019
Tumor Genomic Profiling Guides Patients with Metastatic Gastric Cancer to Targeted Treatment: The VIKTORY Umbrella TrialJeeyun Lee, Seung Tae Kim, Kyung Kim, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
BMC Urology|May 5, 2019
A retrospective feasibility study of biweekly docetaxel in patients with high-risk metastatic castration-naïve prostate cancerSang Eun Yoon, Youjin Kim, Jangho Cho, et al.
Advanced Materials (Deerfield Beach, Fla.)|February 11, 2025
Rapid Drying Principle for High-speed, Pinhole-Less, Uniform Wet Deposition Protocols of Water-Dispersed 2D MaterialsKyeonghun Jeong, Chansoo Kim, Ha Young Lee, et al.
Oncotarget|December 30, 2017
MerTK inhibition by RXDX-106 in MerTK activated gastric cancer cell linesJung Eun Kim, Youjin Kim, Gary Li, et al.
Cancer Research and Treatment|September 8, 2018
Discordance of the PAM50 Intrinsic Subtypes Compared with Immunohistochemistry-Based Surrogate in Breast Cancer Patients: Potential Implication of Genomic Alterations of DiscordanceHee Kyung Kim, Kyung Hee Park, Youjin Kim, et al.
European Journal of Immunology|June 9, 2020
MDSC subtypes and CD39 expression on CD8<sup>+</sup> T cells predict the efficacy of anti-PD-1 immunotherapy in patients with advanced NSCLCJiae Koh, Youjin Kim, Kyoung Young Lee, et al.
Journal of Gastric Cancer|January 5, 2019
Adjuvant Chemotherapy with or without Concurrent Radiotherapy for Patients with Stage IB Gastric Cancer: a Subgroup Analysis of the Adjuvant Chemoradiotherapy in Stomach Tumors (ARTIST) Phase III TrialYoujin Kim, Kyoung-Mee Kim, Min Gew Choi, et al.
Journal of Gastric Cancer|July 20, 2016
The Influence of Metastatic Lymph Node Ratio on the Treatment Outcomes in the Adjuvant Chemoradiotherapy in Stomach Tumors (ARTIST) Trial: A Phase III TrialYoujin Kim, Se Hoon Park, Kyoung-Mee Kim, et al.
Cancer|January 20, 2017
Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01)Youjin Kim, Su Jin Lee, Ji Yun Lee, et al.
Cancer Research and Treatment|April 19, 2024
Analysis of Response and Progression Patterns of Tyrosine Kinase Inhibitors in Recurrent or Metastatic Adenoid Cystic Carcinoma: A Post Hoc Analysis of Two KCSG Phase II TrialsYoujin Kim, Bhumsuk Keam, Eun Joo Kang, et al.
Cancer Discovery|July 19, 2019
Tumor Genomic Profiling Guides Patients with Metastatic Gastric Cancer to Targeted Treatment: The VIKTORY Umbrella TrialJeeyun Lee, Seung Tae Kim, Kyung Kim, et al.
Pageof 11